Pneumococcal Vaccine Label Adds Injection-Site Risk Pneumococcal Vaccine Label Adds Injection-Site Risk

After reports of necrosis at the injection site after the 23-valent pneumococcal vaccine, an FDA investigation has concluded that the benefits of the vaccine outweigh the risks.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news